Last Updated: Jul 15, 2016
- Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.
Zhang Juan, et al. Breast cancer research and treatment 2016 7 - Clinician-Reported Barriers to Implementing Breast Cancer Chemoprevention in the UK: A Qualitative Investigation.
Smith Samuel G et al. Public health genomics 2016 Jul - Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland.
Smyth Lillian et al. Breast cancer research and treatment 2015 Oct 153(3) 573-82 - Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures.
Beitsch Peter et al. Annals of surgical oncology 2016 Jul - Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.
Darlix Amélie, et al. BMC cancer 2016 0 428 - Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
Shin Saeam, et al. Breast cancer research and treatment 2016 7 - Association of CTLA4 and CD28 Gene Variants and Circulating Levels of Their Proteins in Patients with Breast Cancer.
Isitmangil Gulbu, et al. In vivo (Athens, Greece) 0 0 (4) 485-493 - Mu-Opioid Receptor Polymorphisms and Breast Cancer in a Korean Female Adult Population: A Retrospective Study.
Oh Chung-Sik, et al. Journal of breast cancer 2016 6 (2) 206-9 - Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.
Qian Frank, et al. Human genetics 2016 7 - Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.
Musolino A, et al. The pharmacogenomics journal 2016 7 - Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
Gargiulo Piera, et al. BMC cancer 2016 0 (1) 375 - MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
Bennani-Baiti Barbara, et al. PloS one 0 0 (7) e0158573 - Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk.
Shi Joy, et al. Frontiers in oncology 2016 0 136 - Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.
Kotoula Vassiliki, et al. Breast cancer research and treatment 2016 7 - NIH launches largest-ever study of breast cancer genetics in black women
Findings could inform breast cancer disparities, NIH, July 6, 2016
- Human (5235)
- Pathogen (0)
- Human (442)
- Pathogen (0)
- Huamn (119)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario